Perspectives

Marketing Research: Converting Change into Opportunity

What happens to marketing research when marketing budgets are decreased? Marketing research needs to find new ways to do more with less, to change…..you’ve heard it all before... ...

August 22nd, 2011 Read More

It’s Not What the Data Says, but What I Can Do With the Data

   This was a direct and recent quote from the CEO of a biotech client. Senior executives are not focused on methodology but on whether a study yields actionable findings they can use to make decisions. Yet, attending a couple ...

January 18th, 2011 Read More

Only those who risk going too far, find out how far they can go. T. S. Eliot

Most pharma companies have developed research templates to determine what research to conduct prior to the launch of a product, to evaluate its progress over time, or for conducting life cycle research. While every company thinks their templates are unique, ...

August 16th, 2010 Read More

The Yin of Marketing Research

Most people think of marketing research as being about information, data, numbers, etc. I don’t. Marketing research is about understanding of customers and converting understanding into a story, images, charts that management will remember, re-use and re-purpose. As marketing research ...

June 25th, 2010 Read More

The Next Five Years Will Redefine Pharma and Pharma MR

The world of pharma is undergoing dramatic change and those that adapt to these changes the most quickly will thrive and those who don’t will likely not survive. The same is true for Pharma MR. How can we expect Pharma ...

May 16th, 2010 Read More

Change Isn’t Just Smart, It’s a Mandate

The pharmaceutical and biotech industries continue to undergo dramatic change. What worked in the past may no longer work in the future. For those in marketing research, this change presents a rare opportunity. We have the potential to break away ...

March 28th, 2010 Read More

There are no do-overs

There are no do-overs when presenting to senior management. From thirty years’ worth of experience presenting information to the senior executives in pharma and biotech, here’s what they want:  Synthesis, not analysis Clarity of thinking Concise presentations Actionable conclusions ...

May 11th, 2009 Read More